Nurix Therapeutics falls 2% following Q3 earnings as operating expenses up

FormFactor stock rises on $300M Teradyne investment deal

Investing.com · News 22m ago

J&J’s Tremfya shows fistula remission in Crohn’s subgroups

Investing.com · News 24m ago

Onto Innovation wins SK hynix award for HBM defect technology

Investing.com · News 24m ago

ImmuCell reports 46% Q3 sales increase to $8.0 million

Investing.com · News 24m ago

Northern Oil and Gas reports Q3 operations, share buybacks

Investing.com · News 24m ago

International Paper declares quarterly dividend of $0.4625

Investing.com · News 24m ago

Oncolytics receives cancer immunotherapy patent in multiple countries

Investing.com · News 24m ago

Organogenesis announces publication of diabetic foot ulcer trial

Investing.com · News 24m ago

Oil Climbs as Fighting Flares in Middle East, Ukraine

Dow Jones · Markets 25m ago

J&J reports three-year tremfya data for Crohn’s disease

Investing.com · News 32m ago